Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADCY1 | Q08828 | 1/20 | 1.00 |
| ▸ | MAPT | P10636 | 4/20 | 0.69 |
| ▸ | HTT | P42858 | 2/20 | 0.69 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.55 |
| ▸ | TNKS | O95271 | 1/20 | 0.54 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.54 |
| ▸ | GABRP | O00591 | 8/20 | 0.53 |
| ▸ | GABRD | O14764 | 8/20 | 0.53 |
| ▸ | GABRA1 | P14867 | 8/20 | 0.53 |
| ▸ | GABRB1 | P18505 | 8/20 | 0.53 |
| ▸ | GABRG2 | P18507 | 8/20 | 0.53 |
| ▸ | GABRB3 | P28472 | 8/20 | 0.53 |
| ▸ | GABRA5 | P31644 | 8/20 | 0.53 |
| ▸ | GABRA3 | P34903 | 8/20 | 0.53 |
| ▸ | GABRA2 | P47869 | 8/20 | 0.53 |
| ▸ | GABRB2 | P47870 | 8/20 | 0.53 |
| ▸ | GABRA4 | P48169 | 8/20 | 0.53 |
| ▸ | GABRE | P78334 | 8/20 | 0.53 |
| ▸ | GABRA6 | Q16445 | 8/20 | 0.53 |
| ▸ | GABRG1 | Q8N1C3 | 8/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27821368 | 0.75 | ADCY1 (0.60) | ADCY1MAPTALDH1A1TNKSADORA3 | |
| SCHEMBL4650588 | 0.72 | GABRP (0.82) | MAPTALDH1A1TNKSADORA3GABRP | |
| SCHEMBL27582566 | 0.72 | ADCY1 (0.57) | ADCY1MAPTALDH1A1TNKSADORA3 | |
| SCHEMBL4092241 | 0.71 | TTR (0.71) | ADCY1MAPTALDH1A1TNKSADORA3 | |
| SCHEMBL1504213 | 0.71 | ALDH1A1 (1.00) | ADCY1ALDH1A1TNKSADORA3GABRP | |
| SCHEMBL13437399 | 0.71 | KDM4E (0.56) | ADCY1MAPTALDH1A1TNKSADORA3 | |
| SCHEMBL5191884 | 0.71 | ALDH1A1 (0.77) | ADCY1MAPTALDH1A1TNKSADORA3 | |
| SCHEMBL12324681 | 0.71 | ADCY1 (0.55) | ADCY1MAPTALDH1A1TNKSADORA3 | |
| SCHEMBL6957384 | 0.71 | ADCY1 (0.55) | ADCY1MAPTALDH1A1TNKSADORA3 | |
| SCHEMBL27840766 | 0.71 | MAOB (0.56) | ADCY1MAPTALDH1A1TNKSADORA3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240366586-A1 | METHODS AND AGENTS FOR MODULATING THE IMMUNE RESPONSE | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2024-11-07 | — | — | US | claimed |
| WO-2023034413-A2 | METHODS AND AGENTS FOR MODULATING THE IMMUNE RESPONSE | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2023-03-09 | — | — | WO | claimed |
| US-12414949-B2 | Pyrazolyl pyrimidinone compounds and the uses thereof | PURDUE RESEARCH FOUNDATION (US) | 2025-09-16 | — | — | US | disclosed |
| US-20240366586-A1 | METHODS AND AGENTS FOR MODULATING THE IMMUNE RESPONSE | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2024-11-07 | — | — | US | disclosed |
| US-20240083877-A1 | NOVEL SCAFFOLD OF ADENYLYL CYCLASE INHIBITORS FOR CHRONIC PAIN AND OPIOID DEPENDENCE | PURDUE RESEARCH FOUNDATION (US) | 2024-03-14 | — | — | US | disclosed |
| US-20230293523-A1 | PYRAZOLYL PYRIMIDINONE COMPOUNDS AND THE USES THEREOF | PURDUE RESEARCH FOUNDATION (US) | 2023-09-21 | — | — | US | disclosed |
| US-20230250084-A1 | PYRAZOLYL PYRIMIDINONE COMPOUNDS AND THE USES THEREOF | PURDUE RESEARCH FOUNDATION (US) | 2023-08-10 | — | — | US | disclosed |
| US-11690844-B2 | Pyrazolyl pyrimidinone compounds and the uses thereof | PURDUE RESEARCH FOUNDATION (US) | 2023-07-04 | — | — | US | disclosed |
| US-11667623-B2 | Scaffold of adenylyl cyclase inhibitors for chronic pain and opioid dependence | PURDUE RESEARCH FOUNDATION (US) | 2023-06-06 | — | — | US | disclosed |
| WO-2023034413-A2 | METHODS AND AGENTS FOR MODULATING THE IMMUNE RESPONSE | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2023-03-09 | — | — | WO | disclosed |
| US-20210100797-A1 | PYRAZOLYL PYRIMIDINONE COMPOUNDS AND THE USES THEREOF | PURDUE RESEARCH FOUNDATION (US) | 2021-04-08 | — | — | US | disclosed |
| US-20200239447-A1 | NOVEL SCAFFOLD OF ADENYLYL CYCLASE INHIBITORS FOR CHRONIC PAIN AND OPIOID DEPENDENCE | PURDUE RESEARCH FOUNDATION (US) | 2020-07-30 | — | — | US | disclosed |
| US-10662176-B2 | Scaffold of adenylyl cyclase inhibitors for chronic pain and opioid dependence | PURDUE RESEARCH FOUNDATION (US) | 2020-05-26 | — | — | US | disclosed |
| US-20200031785-A1 | METHODS FOR TREATING CHRONIC PAIN AND OPIOID DEPENDENCE USING ADENYLYL CYCLASE INHIBITORS | PURDUE RESEARCH FOUNDATION (US) | 2020-01-30 | — | — | US | disclosed |
| US-10457653-B2 | Adenylyl cyclase inhibitors for chronic pain and opioid dependence | PURDUE RESEARCH FOUNDATION (US) | 2019-10-29 | — | — | US | disclosed |
| US-20190023688-A1 | NOVEL SCAFFOLD OF ADENYLYL CYCLASE INHIBITORS FOR CHRONIC PAIN AND OPIOID DEPENDENCE | PURDUE RESEARCH FOUNDATION (US) | 2019-01-24 | — | — | US | disclosed |
| US-20190002418-A1 | ADENYLYL CYCLASE INHIBITORS FOR CHRONIC PAIN AND OPIOID DEPENDENCE | PURDUE RESEARCH FOUNDATION (US) | 2019-01-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (14 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200239447-A1 | NOVEL SCAFFOLD OF ADENYLYL CYCLASE INHIBITORS FOR CHRONIC PAIN AND OPIOID DEPENDENCE | CAP1, ADCY1, ADCYAP1R1 | ADCY1 2/4885MAPT 3579/4885HTT 3708/4885 |
| US-20190002418-A1 | ADENYLYL CYCLASE INHIBITORS FOR CHRONIC PAIN AND OPIOID DEPENDENCE | CAP1, OPRK1, OPRL1 | ADCY1 4/4885MAPT 3534/4885HTT 4041/4885 |
| US-20240083877-A1 | NOVEL SCAFFOLD OF ADENYLYL CYCLASE INHIBITORS FOR CHRONIC PAIN AND OPIOID DEPENDENCE | CAP1, ADCY1, ADCYAP1R1 | ADCY1 2/4885MAPT 3579/4885HTT 3708/4885 |
| US-12414949-B2 | Pyrazolyl pyrimidinone compounds and the uses thereof | CAP1, ADCY1, ADCYAP1R1 | ADCY1 2/4885MAPT 3370/4885HTT 2598/4885 |
| US-10457653-B2 | Adenylyl cyclase inhibitors for chronic pain and opioid dependence | CAP1, ADCY1, OPRK1 | ADCY1 2/4885MAPT 3356/4885HTT 4193/4885 |
| US-20190023688-A1 | NOVEL SCAFFOLD OF ADENYLYL CYCLASE INHIBITORS FOR CHRONIC PAIN AND OPIOID DEPENDENCE | CAP1, ADCY1, ADCYAP1R1 | ADCY1 2/4885MAPT 3579/4885HTT 3708/4885 |
| US-20200031785-A1 | METHODS FOR TREATING CHRONIC PAIN AND OPIOID DEPENDENCE USING ADENYLYL CYCLASE INHIBITORS | ADCY1, CAP1, ADCY2 | ADCY1 1/4885MAPT 3262/4885HTT 3451/4885 |
| US-11667623-B2 | Scaffold of adenylyl cyclase inhibitors for chronic pain and opioid dependence | CAP1, ADCY1, ADCYAP1R1 | ADCY1 2/4885MAPT 3085/4885HTT 3138/4885 |
| US-11690844-B2 | Pyrazolyl pyrimidinone compounds and the uses thereof | CAP1, ADCY1, ADCYAP1R1 | ADCY1 2/4885MAPT 3370/4885HTT 2598/4885 |
| US-20230250084-A1 | PYRAZOLYL PYRIMIDINONE COMPOUNDS AND THE USES THEREOF | CAP1, ADCY1, ADCYAP1R1 | ADCY1 2/4885MAPT 3370/4885HTT 2598/4885 |
| US-20230293523-A1 | PYRAZOLYL PYRIMIDINONE COMPOUNDS AND THE USES THEREOF | CAP1, ADCY1, ADCYAP1R1 | ADCY1 2/4885MAPT 3370/4885HTT 2598/4885 |
| US-20210100797-A1 | PYRAZOLYL PYRIMIDINONE COMPOUNDS AND THE USES THEREOF | CAP1, ADCY1, ADCYAP1R1 | ADCY1 2/4885MAPT 3370/4885HTT 2598/4885 |
| US-20240366586-A1 | METHODS AND AGENTS FOR MODULATING THE IMMUNE RESPONSE | IL15, IL2, IL17A | ADCY1 1732/4885MAPT 1073/4885HTT 3082/4885 |
| US-10662176-B2 | Scaffold of adenylyl cyclase inhibitors for chronic pain and opioid dependence | CAP1, ADCY1, ADCYAP1R1 | ADCY1 2/4885MAPT 3085/4885HTT 3138/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.